Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
We have a patient where only the adjuvant suspension component was given and not mixed with the Lyophilized IGE antigen component in a Shingles vaccine; We have a patient where only the adjuvant suspension component was given and not mixed with the Lyophilized IGE antigen component in a Shingles vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: We have a patient where only the adjuvant suspension component was given and not mixed with the Lyophilized IGE antigen component in a Shingles vaccine) and inappropriate dose of vaccine administered (Verbatim: We have a patient where only the adjuvant suspension component was given and not mixed with the Lyophilized IGE antigen component in a Shingles vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 18-AUG-2025 The pharmacist mentioned that a patient where only the adjuvant suspension component was given and not mixed with the lyophilized IGE antigen component in a Shingles vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. It was clarified during chat that vaccine involved was Shingrix. Pharmacist did not have demographics for the patient, date of administration, lot number or expiration date for the vaccine.